Monday, December 2, 2013
Translate the new findings to enhance treatment of patients with malignant melanoma cancer researchers.
From translational researchers at UCLA's Jonsson Comprehensive Cancer Center (number of days), published results of a study provide insightful journal Cancer found BRAF inhibitor resistance two key areas critical to tumor how two back-to-back: focus and use to learn how to be resistant to melanoma tumor cells inhibitor with cell signal transduction pathway BRAF-mutant, evolve and limited development cell BRAF inhibitor drug resistance is how black keys.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment